Skip to content

Drug interactions

Dronabinol + Lorlatinib

Severity: Minor

Dronabinol and Lorlatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib is a moderate CYP3A inducer and may lower dronabinol exposure. Reduced cannabinoid effect, such as weaker antiemetic or appetite-stimulating benefit, may result.

What this interaction means in plain words

Dronabinol and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dronabinol belongs to Central Nervous System; Lorlatinib belongs to Oncology.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, increasing the metabolism of dronabinol, a CYP2C9 and CYP3A4 substrate.

What to do

Monitor for reduced dronabinol efficacy and titrate the dose to clinical response if symptom control worsens.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dronabinol and Lorlatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dronabinol with Lorlatinib?

MediHelp rates the interaction as minor. Dronabinol and Lorlatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lorlatinib is a moderate CYP3A inducer and may lower dronabinol exposure. Reduced cannabinoid effect, such as weaker antiemetic or appetite-stimulating benefit, may result.

How serious is the interaction between Dronabinol and Lorlatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced dronabinol efficacy and titrate the dose to clinical response if symptom control worsens.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in